| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Anaissie EJ | |
| Boutati EI | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 999-1008 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management | |
| P478 | volume | 90 |
| Q37734026 | A Fortuitous Turn of Evidence in an Elderly Female - A Case of Pulmonary Fusariosis |
| Q34162712 | An overview of fungal infections |
| Q37428658 | Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium |
| Q33607420 | Aspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils |
| Q81593280 | Azole prophylaxis to prevent invasive fungal infections in patients with severe graft-versus-host disease |
| Q48163274 | Candida glabrata Biofilms: How Far Have We Come? |
| Q36920608 | Changing epidemiology of rare mould infections: implications for therapy |
| Q37157656 | Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel |
| Q85051238 | Combined therapy against murine-disseminated infection by Fusarium verticillioides |
| Q42774815 | Cutaneous Fusarium infection in a renal transplant recipient: a case report |
| Q33969666 | Cutaneous infection caused by Cylindrocarpon lichenicola in a patient with acute myelogenous leukemia. |
| Q40622802 | Dermatitis in the Fringe-Toed Lizard, Acanthodactylus nilsoni Rastegar-Pouyani, 1998 (Sauria: Lacertidae) Associated with Fusarium proliferatum |
| Q24514755 | Developments in fungal taxonomy. |
| Q37437204 | Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: A case report and review of the literature |
| Q34619767 | Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature |
| Q38053092 | Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases |
| Q42008663 | Disseminated fusariosis in a bone marrow transplant patient. |
| Q33408774 | Disseminated fusariosis secondary to neuroblastoma with fatal outcome |
| Q64075702 | Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient |
| Q42761768 | Disseminated fusariosis with endophthalmitis in a patient with hematologic malignancy |
| Q41846501 | Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis |
| Q39652173 | Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis. |
| Q42109334 | Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani |
| Q79300228 | Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient |
| Q46238058 | Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications |
| Q35010686 | Epidemiology of invasive fungal infections in the mediterranean area |
| Q55121434 | Factors Associated to Invasive Fungal Infection in Hispanic Patients with Hematological Malignancies. |
| Q33540545 | Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature |
| Q36768045 | Fungal infections of the CNS: treatment strategies for the immunocompromised patient |
| Q33974961 | Fungemia due to Fusarium sacchari in an immunosuppressed patient |
| Q38128235 | Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. |
| Q42244854 | Fusarium Solani: a causative agent of skin and nail infections |
| Q35066830 | Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification |
| Q37114436 | Fusarium infection in lung transplant patients: report of 6 cases and review of the literature |
| Q27014001 | Fusarium infection: report of 26 cases and review of 97 cases from the literature |
| Q24685627 | Fusarium infections in immunocompromised patients |
| Q40634702 | Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals |
| Q33614273 | Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification |
| Q41728452 | Fusarium solani infection in a kidney transplant recipient |
| Q42728378 | Fusarium solani: An Emerging Fungus in Chronic Diabetic Ulcer |
| Q39712822 | Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain |
| Q56897655 | Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal l |
| Q90400297 | Health-care utilization and outcomes of patients at high risk of invasive fungal infection |
| Q41901358 | Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes. |
| Q39453112 | Identification of Fusarium species involved in human infections by 28S rRNA gene sequencing |
| Q51182454 | Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. |
| Q34144184 | In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results |
| Q37622117 | Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients |
| Q58796975 | Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole |
| Q51149049 | Infections Caused by Fusarium Species in Pediatric Cancer Patients and Review of Published Literature. |
| Q34778557 | Insights into fungal communities in composts revealed by 454-pyrosequencing: implications for human health and safety |
| Q41789613 | Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum |
| Q45992923 | Interplay of neuronal and non-neuronal genes regulates intestinal DAF-16-mediated immune response during Fusarium infection of Caenorhabditis elegans. |
| Q38284994 | Intracranial fusarium fungal abscess in an immunocompetent patient: case report and review of the literature |
| Q37373771 | Invasive fungal infections in patients with cancer in the Intensive Care Unit |
| Q45025817 | Invasive fusariosis in two transplanted children |
| Q33671006 | Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia |
| Q28243864 | Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature |
| Q35848794 | Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. |
| Q46250284 | Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp. |
| Q54219227 | Live-cell imaging of conidial anastomosis tube fusion during colony initiation in Fusarium oxysporum. |
| Q39733388 | Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient |
| Q39461381 | Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. |
| Q34057660 | Molecular and nonmolecular diagnostic methods for invasive fungal infections |
| Q36235415 | Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus |
| Q24603297 | Mucormycosis, pseudallescheriasis, and other uncommon mold infections |
| Q35108357 | Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence |
| Q50195666 | Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure |
| Q40039804 | Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia |
| Q33651853 | Overcoming antifungal resistance |
| Q36047714 | Pentamidine is active in vitro against Fusarium species |
| Q33974908 | Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia. |
| Q55453637 | Recent Advances in the Treatment of Scedosporiosis and Fusariosis. |
| Q33284273 | Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report |
| Q52389635 | Response surface methodology: optimisation of antifungal bioemulsifier from novel Bacillus thuringiensis. |
| Q36531721 | Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients |
| Q36068691 | Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience |
| Q33983629 | Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study |
| Q34336048 | Skin Microvascular Thrombosis in Fusarium Infection in Two Early Biopsied Cases |
| Q39450929 | Specific detection of fusarium species in blood and tissues by a PCR technique |
| Q41537593 | Subcutaneous mycoses: an aetiological study of 15 cases in a tertiary care hospital at Dibrugarh, Assam, northeast India |
| Q36891747 | Successful Outcome of DisseminatedFusariumInfection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia |
| Q42335900 | Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B. |
| Q33951707 | Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient |
| Q40099377 | Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection. |
| Q33592487 | Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods |
| Q35693680 | The challenge of managing fusariosis |
| Q21563336 | The genome of Nectria haematococca: contribution of supernumerary chromosomes to gene expansion |
| Q89475381 | The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes |
| Q37139366 | The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system |
| Q38261303 | Uncommon opportunistic fungal infections of oral cavity: A review |
| Q38536076 | Update on the treatment of disseminated fusariosis: Focus on voriconazole. |
| Q43191432 | Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine |
| Q38582421 | Urinary Tract Infection (UTI) Caused by Fusarium proliferatum in an Agranulocytosis Patient and a Review of Published Reports |
| Q41842848 | Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates |
| Q36696390 | Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia. |
| Q37060341 | Will resistance in fungi emerge on a scale similar to that seen in bacteria? |
| Q64065164 | infection-induced partial failure of free anterolateral thigh musculocutaneous flap: Case report |
Search more.